1.61 USD
↗ 0.02 (0.94%)PRE MARKET (AS OF 04:30 AM EDT)
ProKidney Corp. Class A Ordinary Shares
PROKNASDAQ • USD
Market: OPEN
ProKidney Corp. Class A Ordinary Shares (PROK) trades at $1.61 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, PROK trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Jul 21, 2026.
Open?$1.61
High?$1.61
Low?$1.61
Prev. Close?$1.60
Volume?205
Avg. Volume?1.4M
VWAP?$1.61
Rel. Volume?0.00x
Bid / Ask
Bid?$1.35 × 100
Ask?$1.83 × 100
Spread?$0.48
Midpoint?$1.59
Valuation & Ratios
Market Cap?328.3M
Shares Out?205.2M
Float?88.1M
Float %?42.9%
P/E Ratio?N/A
P/B Ratio?-0.32
EPS?-$0.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
Employees
231
Market Cap
320.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2022-07-12
Address
2000 FRONTIS PLAZA BLVD.
WINSTON-SALEM, NC 27103
Phone: 336-999-7028
WINSTON-SALEM, NC 27103
Phone: 336-999-7028
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?43
Short Sent.?14
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.57Distress
Confidence?66%Moderate
Short InterestSqueeze Risk
Short % of Float?22.06%Squeeze Risk
Short Interest?19.4M
Days to Cover?10.0
Free Float88.1M
Avg Daily Volume1.9M
Settlement Date2026-06-30
Financial Health
Current Ratio?9.06Strong
Quick Ratio?9.06Strong
Cash Ratio?3.93Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-0.32CHEAP▾
S&P97
P/S?369.31HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.4CHEAP▾
S&P97
EV/Sales?254.70HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?7.1%FAIR▾
Peers50
S&P23
ROA?-24.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-150055000
Enterprise Value?$226.4M
Fundamentals ratios updated end of day